• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Oric Pharmaceuticals Inc (NQ: ORIC )

    9.340 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 9
    Open 9.340
    Bid (Size) 9.370 (1)
    Ask (Size) 9.420 (10)
    Prev. Close 9.340
    Today's Range 9.340 - 9.340
    52wk Range 5.270 - 16.65
    Shares Outstanding 54,532,614
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
    From Attovia Therapeutics, Inc.
    Via GlobeNewswire
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From ORIC Pharmaceuticals
    Via GlobeNewswire

    Performance

    YTD
    +2.19%
    +2.19%
    1 Month
    +8.60%
    +8.60%
    3 Month
    -12.46%
    -12.46%
    6 Month
    +13.21%
    +13.21%
    1 Year
    +17.63%
    +17.63%

    More News

    Read More
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    ORIC Pharmaceuticals Inc. (NASDAQ: ORIC) is a Stock Spotlight on 3/1
    Via Investor Brand Network
    ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    ORIC Stock Earnings: ORIC Pharmaceuticals Beats EPS for Q1 2024
    Via InvestorPlace
    ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
    Via Benzinga
    ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    These Analysts Revise Their Forecasts On ORIC Pharmaceuticals After Q4 Results
    Via Benzinga
    ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    MicroMarvel - ORIC Pharmaceutical - Fights Cancer
    Via Talk Markets
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
    From ORIC Pharmaceuticals
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.